Bozok University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02578719
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ayşe Belpınar | BETÜL KUŞ | Bozok University | Bozok University Neurology Department | Yozgat Bozok University

Active Ingredients

Drugs in Phase 4 Trials (2)

levobupivacaine (chirocaine) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Migraine Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2